Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration
- 1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; Innovation and eHealth Center, Carol Davila University of Medicine and Pharmacy Bucharest, Romania. Electronic address: [email protected]
- 2"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; National Institute of Neurology and Neurovascular Diseases, Bucharest, Romania
Abstract
Brain aging involves progressive declines in neuroplasticity, metabolic flexibility, cerebrovascular integrity and immune homeostasis. Although traditionally viewed as brain-intrinsic, growing evidence indicates that peripheral metabolic organs substantially influence neural aging trajectories. Among these, adipose tissue is increasingly recognized as a dynamic endocrine and immune organ capable of modulating central nervous system (CNS) structure and function across the lifespan. Epidemiological, neuroimaging and experimental studies consistently link adipose tissue dysfunction, particularly the expansion and inflammatory remodeling of visceral fat depots, to accelerated brain aging, cognitive decline and increased susceptibility to neurodegenerative disease. These relationships extend beyond conventional cardiometabolic risk, implicating adipose-derived mechanisms with direct relevance for neural aging. Chronic low-grade inflammation, impaired insulin signaling, dyslipidemia, adipokine imbalance and senescence-associated secretory activity originating in adipose tissue act on the aging brain by promoting microglial dysfunction, cerebrovascular impairment, blood-brain barrier (BBB) disruption and synaptic vulnerability. In parallel, adipose-derived extracellular vesicles and microRNAs have been identified as direct molecular mediators of adipose-brain communication. Importantly, adipose tissue is structurally and functionally heterogeneous, and its impact on brain aging is strongly depot- and context-dependent. While dysfunctional visceral adipose tissue amplifies neuroinflammatory and neurodegenerative processes, preserved subcutaneous and thermogenic depots may support brain resilience by sustaining metabolic homeostasis and neurotrophic signaling. By integrating molecular, translational and human evidence, this review frames adipose tissue as a central and modifiable systemic determinant of brain aging. Framing brain aging within a peripheral metabolic context reconciles findings across disciplines and highlights adipose-targeted interventions as promising strategies for preserving cognitive function and reducing neurodegenerative risk.
Related
- Correlation between systemic branched-chain amino acid metabolism and tear fluid inflammation with visual quality of life in patients with dry eye disease
- Astaxanthin and Related Carotenoids as a Dual Modulator of Nrf2 and NF-κB in Bisretinoid-Induced Retinal Damage: Mechanistic Rationale and Evidence Gaps.
- Astrocyte lipid metabolism in brain health and neurodegeneration: from regulatory hub to maladaptive stressor.
- Enhancement of Endocannabinoid Signaling by Dual MAGL/ABHD6 Inhibition Reduces Neurodegeneration and Neuro-Inflammation Following AMPA-Mediated Excitotoxicity
- Exercise oncology and tumor sterol metabolism: An emerging mechanistic frontier
BibTeX
@article{treteanu2026adipose,
title = {{Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration}},
author = {Andreea Ramona Treteanu and Manea Maria Mirabela},
journal = {Brain Research},
year = {2026},
month = jun,
doi = {10.1016/j.brainres.2026.150414},
url = {https://doi.org/10.1016/j.brainres.2026.150414},
note = {CC BY},
}
RIS
TY - JOUR
TI - Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration
AU - Andreea Ramona Treteanu
AU - Manea Maria Mirabela
PY - 2026
DA - 2026/06/01
JO - Brain Research
DO - 10.1016/j.brainres.2026.150414
UR - https://doi.org/10.1016/j.brainres.2026.150414
AB - Brain aging involves progressive declines in neuroplasticity, metabolic flexibility, cerebrovascular integrity and immune homeostasis. Although traditionally viewed as brain-intrinsic, growing evidence indicates that peripheral metabolic organs substantially influence neural aging trajectories. Among these, adipose tissue is increasingly recognized as a dynamic endocrine and immune organ capable of modulating central nervous system (CNS) structure and function across the lifespan. Epidemiological, neuroimaging and experimental studies consistently link adipose tissue dysfunction, particularly the expansion and inflammatory remodeling of visceral fat depots, to accelerated brain aging, cognitive decline and increased susceptibility to neurodegenerative disease. These relationships extend beyond conventional cardiometabolic risk, implicating adipose-derived mechanisms with direct relevance for neural aging. Chronic low-grade inflammation, impaired insulin signaling, dyslipidemia, adipokine imbalance and senescence-associated secretory activity originating in adipose tissue act on the aging brain by promoting microglial dysfunction, cerebrovascular impairment, blood-brain barrier (BBB) disruption and synaptic vulnerability. In parallel, adipose-derived extracellular vesicles and microRNAs have been identified as direct molecular mediators of adipose-brain communication. Importantly, adipose tissue is structurally and functionally heterogeneous, and its impact on brain aging is strongly depot- and context-dependent. While dysfunctional visceral adipose tissue amplifies neuroinflammatory and neurodegenerative processes, preserved subcutaneous and thermogenic depots may support brain resilience by sustaining metabolic homeostasis and neurotrophic signaling. By integrating molecular, translational and human evidence, this review frames adipose tissue as a central and modifiable systemic determinant of brain aging. Framing brain aging within a peripheral metabolic context reconciles findings across disciplines and highlights adipose-targeted interventions as promising strategies for preserving cognitive function and reducing neurodegenerative risk.
SN - 0006-8993
SN - 1872-6240
ER -